Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development
Xiaoye Duan, Xiaoye Duan, Weihao Wang and 3 more
Frontiers in Oncology · 2021
doi:10.3389/fonc.2021.730038 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The relationship between type 2 diabetes mellitus (T2DM) and pancreatic cancer (PC) is complex. Diabetes is a known risk factor for PC, and new-onset diabetes (NOD) could be an early manifestation of PC that may be facilitate the early diagnosis of PC. Metformin offers a clear benefit of inhibiting PC, whereas insulin therapy may increase the risk of PC development. No evidence has shown that novel hypoglycemic drugs help or prevent PC. In this review, the effects of T2DM on PC development are summarized, and novel strategies for the prevention and treatment of T2DM and PC are discussed.
Abstract licence: CC BY
References120
- 6.
- 14.
- 37.
37 more references, whose wording the paper’s licence keeps private.
All 120 referencesReads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.